Early management of sight threatening retinopathy in incontinentia pigmenti.


Journal

Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602

Informations de publication

Date de publication:
27 08 2020
Historique:
received: 06 04 2020
accepted: 13 08 2020
entrez: 29 8 2020
pubmed: 29 8 2020
medline: 22 6 2021
Statut: epublish

Résumé

Early blindness secondary to incurable retinal detachment is one of the main complications of incontinentia pigmenti (IP). The efficiency of ophthalmological management for preventing such evolution has not been proven. The objective of this retrospective study was to report a screening and treatment strategy of the vascular retinopathy in newborns and infants with IP. All files of patients diagnosed with IP within the two first months of life in a single tertiary referral center, between 2010 and 2015, were retrospectively included. The minimum follow-up duration was three years. Patients had undergone systematic indirect ophthalmoscopy examination, looking for signs of peripheric retinal vasculopathy, according to a standardized schedule: at diagnosis, at age 1, 2, 3, 6, 9, 12, 18 and 24 months, and then once a year. Urgent laser therapy was performed under anesthesia in case of signs of retinal ischemia. Nineteen children files (17 girls) were studied. Median age at IP diagnosis was 1 day [0-44]; median age at first retinal evaluation was 25 days. Retinal manifestations occurred in 7 patients (n = 10/38 eyes, 26.3%); they were diagnosed at median age 19 days [3-59]. These patients underwent one or two ablative session per eye (mean 1.7, median 2), under general anaesthesia. No retinal detachment or fold occurred during the follow-up (median 6 years [3-9.8]). Ocular screening should be performed in all cases of IP as soon as possible after diagnosis. A strict ophthalmological monitoring and prophylactic treatment of retinal vasculopathy can efficiently prevent the early blinding complications of the disease.

Sections du résumé

BACKGROUND
Early blindness secondary to incurable retinal detachment is one of the main complications of incontinentia pigmenti (IP). The efficiency of ophthalmological management for preventing such evolution has not been proven. The objective of this retrospective study was to report a screening and treatment strategy of the vascular retinopathy in newborns and infants with IP.
RESULTS
All files of patients diagnosed with IP within the two first months of life in a single tertiary referral center, between 2010 and 2015, were retrospectively included. The minimum follow-up duration was three years. Patients had undergone systematic indirect ophthalmoscopy examination, looking for signs of peripheric retinal vasculopathy, according to a standardized schedule: at diagnosis, at age 1, 2, 3, 6, 9, 12, 18 and 24 months, and then once a year. Urgent laser therapy was performed under anesthesia in case of signs of retinal ischemia. Nineteen children files (17 girls) were studied. Median age at IP diagnosis was 1 day [0-44]; median age at first retinal evaluation was 25 days. Retinal manifestations occurred in 7 patients (n = 10/38 eyes, 26.3%); they were diagnosed at median age 19 days [3-59]. These patients underwent one or two ablative session per eye (mean 1.7, median 2), under general anaesthesia. No retinal detachment or fold occurred during the follow-up (median 6 years [3-9.8]).
CONCLUSION
Ocular screening should be performed in all cases of IP as soon as possible after diagnosis. A strict ophthalmological monitoring and prophylactic treatment of retinal vasculopathy can efficiently prevent the early blinding complications of the disease.

Identifiants

pubmed: 32854719
doi: 10.1186/s13023-020-01509-2
pii: 10.1186/s13023-020-01509-2
pmc: PMC7450972
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

223

Références

Br J Ophthalmol. 2011 Jan;95(1):11-6
pubmed: 20829317
Acta Ophthalmol Scand. 2000 Jun;78(3):348-53
pubmed: 10893071
J AAPOS. 2001 Aug;5(4):258-9
pubmed: 11507587
J Pediatr Ophthalmol Strabismus. 2013 Oct 29;50 Online:e52-4
pubmed: 25313552
Arch Dermatol. 2003 Sep;139(9):1163-70
pubmed: 12975158
Pulm Circ. 2018 Oct-Dec;8(4):2045894018793983
pubmed: 30036148
Surv Ophthalmol. 2017 May - Jun;62(3):257-276
pubmed: 28012875
Am J Ophthalmol. 1990 Dec 15;110(6):701-2
pubmed: 2248338
Nature. 2000 May 25;405(6785):466-72
pubmed: 10839543
Retin Cases Brief Rep. 2017 Fall;11(4):352-355
pubmed: 27472514
Ophthalmic Surg Lasers Imaging Retina. 2019 Feb 1;50(2):e33-e37
pubmed: 30768227
Ophthalmic Surg Lasers Imaging Retina. 2015 Jun;46(6):650-7
pubmed: 26114846
Br J Ophthalmol. 2014 Jun;98 Suppl 1:i7-10
pubmed: 24326326
JAMA Ophthalmol. 2015 May;133(5):542-8
pubmed: 25695859

Auteurs

Sarah Michel (S)

Ophthalmology Department and Rare Eye Disease Reference Center OPHTARA, Necker-Enfants malades University Hospital, AP-HP, Paris, France. sarahmichelawad@gmail.com.

Clothilde Reynaud (C)

Ophthalmology Department and Rare Eye Disease Reference Center OPHTARA, Necker-Enfants malades University Hospital, AP-HP, Paris, France.

Alejandra Daruich (A)

Ophthalmology Department and Rare Eye Disease Reference Center OPHTARA, Necker-Enfants malades University Hospital, AP-HP, Paris, France.
INSERM, UMRS1138, Team 17, From Physiopathology of Ocular Diseases to Clinical Development, Paris University, Paris, France.

Smail Hadj-Rabia (S)

Dermatology Department and Genodermatoses and Rare Skin Diseases Reference Center MAGEC, Necker-Enfants malades University Hospital, AP-HP, Paris, France.
INSERM U1163, Institut IMAGINE, Paris, France.

Dominique Bremond-Gignac (D)

Ophthalmology Department and Rare Eye Disease Reference Center OPHTARA, Necker-Enfants malades University Hospital, AP-HP, Paris, France.
INSERM, UMRS1138, Team 17, From Physiopathology of Ocular Diseases to Clinical Development, Paris University, Paris, France.

Christine Bodemer (C)

Dermatology Department and Genodermatoses and Rare Skin Diseases Reference Center MAGEC, Necker-Enfants malades University Hospital, AP-HP, Paris, France.
INSERM U1163, Institut IMAGINE, Paris, France.

Matthieu P Robert (MP)

Ophthalmology Department and Rare Eye Disease Reference Center OPHTARA, Necker-Enfants malades University Hospital, AP-HP, Paris, France.
Borelli Centre, UMR 9010, CNRS-SSA-ENS Paris Saclay-Paris University, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH